MEDTRONIC PUERTO RICO OPERATIONS CO. PERCEPT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number B35200 |
Device Problems
Break (1069); Intermittent Continuity (1121)
|
Patient Problems
Muscular Rigidity (1968); Chills (2191); Dysphasia (2195); Discomfort (2330); Ambulation Difficulties (2544); Unspecified Nervous System Problem (4426); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/02/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id neu_unknown_lead, lot#: unknown, product type: lead.Other relevant device(s) are: product id: neu_unknown_lead, serial/lot #: unknown.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the patient had a replacement on (b)(6) 2022.The following days were very difficult to treat but varied good effect and varied untreated.Most bothersome symptoms were in the right half of the body.Now calmer, but with increased mobility in the right half of the body and then visibly in the right leg.The patient felt that the stimulation was turning off/on.The patient experienced symptoms such as drooling, cold sweats, slow speech, slow movements, hyperactivity, and unsteady gait.Impedances were checked and all good on both leads, and the stimulation was on.The patient tried walking in the corridor when the stimulation was on.Then it showed the patient could walk for one second relatively well, to becoming hypermobile, unable to speak, to becoming cold sweaty, quite stiff in the body and legs started to fold and that the steps were coming shorter and legs dragged.Impedances were taken in conjunction with walking and they continued to show green/normal.The patient experienced their symptoms in random movements, not a specific position.They didn't experience a shocking sensation either.An x-ray was done (b)(6) 2022 and results at first appeared to show some kind of cable break left lead, but it was difficult to interpret the picture, and impedances were all within range.(b)(6) 2022 the patient was examined again at the clinic and electrode impedances were within range.Palpating was done as well with no issue.Data reports were sent to be examined.
|
|
Manufacturer Narrative
|
Continuation of d10: product id neu_unknown_lead lot# unknown: product type lead medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received: it was reported that after a couple days the patient's problems had resolved.Fortunately they were satisfied with their therapy results now.Their symptoms were reduced and therapy worked well.There would be no further investigation.
|
|
Search Alerts/Recalls
|
|
|